Blueprint Medicines Corporation DSO Ratio 2011-2026 | BPMC

Annual DSO Ratio Blueprint Medicines Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
42.5	48.6	43.5	32.7	1.78	128	-	-	47	109	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
128	1.78	56.7

Quarterly DSO Ratio Blueprint Medicines Corporation

2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
47	-	53.7	47.9	48.8	-	61.3	51.6	38.6	-	13.4	35.9	39.2	-	82.8	101	88.3	-	0.87	77.6	57.4	1.17	6.62	11.8	45.4	5.65	5.33	0.07	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
101	0.07	40

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
ADMA Biologics ADMA	74.6	$ 16.45	0.43 %	$ 3.92 B	USA
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
AbCellera Biologics ABCL	173	$ 3.64	-1.89 %	$ 1.09 B	Canada
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.6	$ 0.83	4.23 %	$ 4.53 M	China
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
ANI Pharmaceuticals ANIP	114	$ 76.75	0.85 %	$ 1.48 B	USA
Apellis Pharmaceuticals APLS	115	$ 19.93	-1.14 %	$ 2.51 B	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Athersys ATHX	22.6	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	47.5	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	105	$ 163.82	-0.14 %	$ 8.15 B	USA
BridgeBio Pharma BBIO	52.4	$ 66.98	3.8 %	$ 12.8 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
BioMarin Pharmaceutical BMRN	88.9	$ 60.75	3.79 %	$ 11.7 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	4.13	$ 3.24	1.73 %	$ 1.16 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Capricor Therapeutics CAPR	31.9	$ 25.71	-0.5 %	$ 688 M	USA
Agios Pharmaceuticals AGIO	47.4	$ 28.49	0.04 %	$ 1.65 B	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA